LifeVantage Sets Nov. 6 Annual Meeting; Board Pushes Key Governance Votes

TL;DR

**LFVN's upcoming annual meeting is a rubber stamp for management, but the 2017 Long-Term Incentive Plan amendment could be a stealthy dilution play, so watch that closely.**

AI Summary

LifeVantage Corporation (LFVN) is holding its Fiscal Year 2026 Annual Meeting on November 6, 2025, to address four key proposals. Stockholders will vote on the election of seven directors for one-year terms, an advisory 'Say-On-Pay' resolution for named executive officers' compensation, the ratification of Deloitte & Touche, LLP as the independent auditor for fiscal year 2026, and an amendment to the 2017 Long-Term Incentive Plan. The Board of Directors unanimously recommends a 'FOR' vote on all proposals. As of the September 15, 2025 Record Date, there were 12,691,009 shares of common stock outstanding and entitled to vote. The company is utilizing the SEC's e-proxy rules, mailing a Notice of Internet Availability of Proxy Materials around September 19, 2025, to reduce costs and environmental impact. The company will pay approximately $10,000 plus expenses to Sodali & Co. for proxy solicitation assistance.

Why It Matters

This DEF 14A filing outlines critical governance decisions for LifeVantage, directly impacting investor confidence and executive oversight. The 'Say-On-Pay' vote allows shareholders to voice their opinion on executive compensation, a key factor in attracting and retaining top talent, while the 2017 Long-Term Incentive Plan amendment could influence future equity awards and dilution. Ratifying Deloitte ensures continued financial transparency, crucial for market trust. In a competitive health and wellness market, strong governance and clear compensation strategies are vital for LFVN to maintain its market position and attract capital.

Risk Assessment

Risk Level: medium — The risk level is medium due to the proposed amendment to the 2017 Long-Term Incentive Plan (Proposal 4). While the filing doesn't detail the amendment, changes to incentive plans can lead to increased share dilution or alter executive compensation structures, potentially impacting shareholder value. Additionally, the election of seven directors (Proposal 1) and the advisory 'Say-On-Pay' vote (Proposal 2) are standard but carry inherent governance risks if shareholders are dissatisfied with current leadership or compensation practices.

Analyst Insight

Investors should carefully review the details of the proposed amendment to the 2017 Long-Term Incentive Plan (Proposal 4) once available, as it could impact future share dilution and executive incentives. Vote 'FOR' the ratification of Deloitte (Proposal 3) to ensure continued financial oversight, but consider the implications of the director elections (Proposal 1) and 'Say-On-Pay' (Proposal 2) based on the company's recent performance and your investment thesis.

Key Numbers

• November 6, 2025 — Annual Meeting Date (Date of the Fiscal Year 2026 Annual Meeting of Stockholders)
• September 15, 2025 — Record Date (Date for determining stockholders entitled to vote at the Annual Meeting)
• 12,691,009 — Shares Outstanding (Number of common stock shares outstanding and entitled to vote as of the Record Date)
• 7 — Number of Directors (Number of directors to be elected for a one-year term)
• $10,000 — Sodali & Co. Fee (Approximate fee paid to Sodali & Co. for proxy solicitation services)
• June 30, 2026 — Fiscal Year End (End date for the fiscal year for which Deloitte is appointed auditor)
• 1:00 P.M. Mountain Time — Meeting Time (Scheduled start time for the Annual Meeting)
• 3300 Triumph Blvd., Suite 700, Lehi, Utah 84043 — Meeting Location (Physical address where the Annual Meeting will be held)

Key Players & Entities

• LifeVantage Corporation (company) — Registrant and subject of the DEF 14A filing
• Steven R. Fife (person) — President and Chief Executive Officer of LifeVantage Corporation
• Deloitte & Touche, LLP (company) — Independent registered public accounting firm for fiscal year ending June 30, 2026
• Sodali & Co. (company) — Proxy solicitation firm engaged by LifeVantage Corporation
• SEC (regulator) — U.S. Securities and Exchange Commission, governing body for proxy rules
• Computershare Trust Company, Inc. (company) — Transfer agent for LifeVantage Corporation
• NYSE Stock Exchange (regulator) — Governing body for broker non-vote rules

FAQ

Industry Context

LifeVantage Corporation operates in the direct selling industry, often referred to as multi-level marketing (MLM), which focuses on health, wellness, and anti-aging products. This sector is characterized by network-based sales models, reliance on independent distributors, and significant marketing efforts. The industry faces ongoing scrutiny regarding its business practices and regulatory compliance, particularly concerning distributor earnings and product claims.

Regulatory Implications

As a direct selling company, LifeVantage is subject to regulations concerning marketing practices, product claims, and compensation plans for its distributors. The Federal Trade Commission (FTC) and state attorneys general monitor these practices to prevent deceptive or unfair conduct. Compliance with evolving consumer protection laws and direct selling guidelines is crucial to avoid penalties and maintain business operations.

What Investors Should Do

1. Review the proxy statement thoroughly.
2. Vote your shares by the deadline.
3. Note the Record Date of September 15, 2025.
4. Be aware of the Annual Meeting date and time: November 6, 2025, at 1:00 P.M. Mountain Time.

Key Dates

• 2025-11-06: Fiscal Year 2026 Annual Meeting of Stockholders — Stockholders will vote on director elections, executive compensation, auditor ratification, and an incentive plan amendment.
• 2025-09-15: Record Date — Determines which stockholders are entitled to vote at the Annual Meeting.
• 2025-09-19: Mailing of Notice of Internet Availability of Proxy Materials — Informs stockholders how to access proxy materials online, reducing costs and environmental impact.

Glossary

DEF 14A

A filing with the U.S. Securities and Exchange Commission (SEC) that provides detailed information about a company's annual meeting of stockholders, including proposals to be voted on and executive compensation. (This document is the primary source of information for the annual meeting and the matters being voted upon by LifeVantage Corporation's stockholders.)

Proxy Statement

A document that a company must provide to shareholders before a shareholder meeting, containing information about the matters to be voted on. (This is the core document for the Annual Meeting, detailing the proposals and providing information for stockholders to make informed voting decisions.)

Named Executive Officers (NEOs)

The top executive officers of a company whose compensation is disclosed in the proxy statement. (Their compensation is subject to a 'Say-On-Pay' advisory vote by stockholders.)

Say-On-Pay

A non-binding shareholder vote on the compensation of the company's named executive officers. (Allows shareholders to express their opinion on the company's executive compensation practices.)

Independent Auditor

An external accounting firm hired by a company to audit its financial statements and provide an opinion on their fairness and accuracy. (Stockholders will vote to ratify the appointment of Deloitte & Touche, LLP as the independent auditor for fiscal year 2026.)

Long-Term Incentive Plan

A compensation plan designed to reward employees for achieving long-term company goals, often through stock options or other equity awards. (An amendment to LifeVantage's 2017 Long-Term Incentive Plan is a key proposal to be voted on at the meeting.)

Record Date

A specific date set by a company to determine which shareholders are eligible to receive dividends, vote at a shareholder meeting, or receive other distributions. (Establishes the pool of eligible voters for the November 6, 2025 Annual Meeting.)

Year-Over-Year Comparison

This analysis is based on the DEF 14A for the Fiscal Year 2026 Annual Meeting. Specific comparative data to a prior filing (e.g., FY2025 DEF 14A) regarding revenue growth, margin changes, or the emergence of new risks is not available within the provided text. The document focuses on the upcoming meeting's agenda and proposals rather than a year-over-year financial performance review.

Key Financial Figures

• $10,000 — ed to pay Sodali a fee of approximately $10,000 plus reimbursement of expenses for thei

Filing Documents

• lfvn-20250917.htm (DEF 14A) — 945KB
• lfvn-20250917_g1.jpg (GRAPHIC) — 92KB
• lfvn-20250917_g2.jpg (GRAPHIC) — 94KB
• lfvn-20250917_g3.jpg (GRAPHIC) — 800KB
• lfvn-20250917_g4.jpg (GRAPHIC) — 602KB
• 0001628280-25-042171.txt ( ) — 5151KB
• lfvn-20250917.xsd (EX-101.SCH) — 2KB
• lfvn-20250917_def.xml (EX-101.DEF) — 2KB
• lfvn-20250917_lab.xml (EX-101.LAB) — 3KB
• lfvn-20250917_pre.xml (EX-101.PRE) — 1KB
• lfvn-20250917_htm.xml (XML) — 96KB

EXECUTIVE COMPENSATION 28

EXECUTIVE COMPENSATION 28 SUMMARY COMPENSATION TABLE 28 OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END 37 PAY-VERSUS-PERFORMANCE 40 AUDIT RELATED MATTERS 44

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 45

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 45 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 47 CODE OF ETHICS 47 COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT 48 HOUSEHOLDING OF PROXY MATERIALS 48 ANNUAL REPORT ON FORM 10-K 48 OTHER MATTERS 48 ANNEX A - 2017 LONG-TERM INCENTIVE PLAN A-1 iii LifeVantage Corporation 3300 Triumph Blvd., Suite 700 Lehi, Utah 84043 _________________________________________________________________________________________ PROXY STATEMENT FOR LIFEVANTAGE CORPORATION FISCAL YEAR 2026 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON November 6, 2025 _________________________________________________________________________________________ INFORMATION CONCERNING VOTING AND SOLICITATION OF PROXY General This proxy statement is furnished to stockholders of LifeVantage Corporation, a Delaware corporation, sometimes referred to as "we," "us," "our," the "Company" or "LifeVantage," in connection with the solicitation of proxies for use at the fiscal year 2026 Annual Meeting of Stockholders or any a djournment or postponement thereof (the "Annual Meeting" or the "Fiscal Year 2026 Annual Meeting") of LifeVantage to be held in person on November 6, 2025 , at 1:00 P.M. Mountain Time, at our offices located at 3300 Triumph Blvd., Suite 700, Lehi, Utah 84043, for t he purposes set forth in the Notice of Annual Meeting. This solicitation of proxies is made on behalf of the Company's Board of Directors (the "Board"). Our Fiscal Year Our fiscal year ends on June 30 of each year. In this proxy statement, when we refer to our fiscal year, we mean the twelve-month period ending on June 30 of the stated year. For example, "fiscal year 2026" refers to the twelve-month period from July 1, 2025 through June 30, 2026. Why am I receiving these materials? You are receiving these proxy materials from us because you were a stockholder of record at the close of business on September 15, 2025 (the "Record Date").

View Full Filing

View this DEF 14A filing on SEC EDGAR